Professor Stuart Pitson holds the position of NRF Professor of Brain Tumour Research and Head of the Molecular Therapeutics Laboratory at the Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide. After gaining his PhD at La Trobe University, he undertook postdoctoral positions at Wageningen University in The Netherlands, and the University of New South Wales, before moving to Adelaide in 1998 to begin his current research interest in examining cell signalling pathways Driving cancer development, progression and therapy resistance.
His work focuses on the targeting of sphingolipid metabolism and signalling for therapeutic benefit in cancer and other conditions, and on the development and use of advanced patient-derived xenograft models for pre-clinical evaluation of new anti-cancer approaches for adult and paediatric brain cancers, and some blood cancers.
He has authored over 175 scientific publications, held prestigious fellowships from the National Health and Medical Research Council, and recently co-founded two spin-out companies, based on his research through separate multi-million dollar investments, to translate his research to the clinic.
“I’m really pleased to have joined the outstanding team at CBCF, and look forward to contributing to the great work they do towards improving outcomes for people with brain tumours.”